Androgen receptor-related diseases: what do we know?

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• The androgen receptor (AR) and its signaling pathway are vital for male sexual differentiation and organ development.
• AR abnormalities are implicated in various diseases, including androgen insensitivity syndrome, spinal bulbar muscular atrophy, benign prostatic hyperplasia, and prostate cancer.

Purpose of the Study:

• To provide an overview of androgen function and AR-mediated diseases.
• To discuss the association of specific diseases with AR mutations and post-transcriptional modifications.
• To introduce recent therapeutic strategies targeting AR transactivation in prostate cancer.

Main Methods:

• Review of existing literature on androgen receptor function and associated diseases.
• Analysis of the role of mutations and post-transcriptional modifications in AR-related pathologies.
• Exploration of emerging therapeutic targets, including microRNAs (miRNAs), for AR-driven cancers.

Main Results:

• Androgen-AR signaling is fundamental to male physiology.
• Specific mutations and modifications of the AR are key factors in disease pathogenesis.
• Novel therapeutic approaches are being developed to modulate AR activity.

Conclusions:

• Understanding androgen-AR signaling is critical for diagnosing and treating related diseases.
• Targeting AR at post-transcriptional stages offers promising therapeutic avenues, particularly for prostate cancer.
• Further research into AR modifications and miRNA therapeutics holds significant clinical potential.